Pratia Paramita, Asvin Nurulita, Ruland DN Pakasi


Platelets have a central role in the pathogenesis of ACS. Immature Platelet Fraction (IPF) considered as a potential marker of the platelet activation process and platelet turnover process. Immature platelets have greater prothrombotic potential and aggregate more rapidly with collagen that affects platelet hemostasis potential that may contribute to the formation of thrombus. Therefore IPF is associated with the progression of coronary heart disease. MPV values reflect platelet activation. A cross sectional study was held in the clinical pathology laboratory of Dr. WahidinSudirohusodo Hospital Makassar during September-November 2016. 67 samples underwent and declared ACS by the physician. 67 patients with ACS were involved with a distribution of 30 patients STEMI (44.8%), 30 patients NSTEMI (44.8%), and 7 patients UAP (10.4%). Subjects are mostly male (73.1%) and young adult age (82.1%). There was significant difference of IPF value especially in STEMI group with mean 3,1 (p = 0,004) and no significant difference of MPV value in ACS group.Pearson correlation test showed there was positive correlation with weak strength of IPF and MPV values in ACS patients (p = 0.02, r = 0.388). There was a significant difference between IPF scores according to GRACE score (p = 0.005).  Increased  IPF value in STEMI group. The IPF score can be considered as a risk stratification of ACS patients replacing GRACE score. There was a positive correlation with weak strength of IPF and MPV value in ACS patients.


Mean Platelet Volume, Immature Platelet Fraction, GRACE score


Pedoman Tatalaksana Sindrom Koroner. PERKI 2015; Hal.1-10.

Chang t, et al. Mean Platelet Volume as Prognostic Marker in Patients with Acute Coronary Syndrome. Rev Argent Cardiol. 2015;83:292-8.

Erik , Anne-Mette et al. Immature Platelets in patients with Acute Coronary Syndromes. Cardiovascular. Journal of Denmark. 2009 ; Vol.151-156.

Jose R et all. Mean Platelet Volume ; a potential biomarker of the risk and prognosis of heart disease. Journal of Polandia. 2016 Sep ; Vol.31;1009-1017

Moh.Eza et all. Reticulated platelets : analytical aspects and clinical utility. Clin Chem Lan Med 2014 ; 52 (8); 1107-1117

Mumpuni all. Platelet and Acute Coronary Syndrome. Journal Form Med. 2016 ; Vol.3; 2380-2658

Hoffbrand,P.A.H. Moss, andI.E. Pettit. (2016) Platelet, blood coagulation and Haemostasis. In: Essential Haematology I A.V. 7th edition. Blackwell Publishing. 265-277

Dacie J.V, Lewis S.M. (2010) Platelet Morphology. In : Practical Haematology 10th edition. Churchil Livingstone. 191-193

Sysmex. (2015). Understanding Your IPF Value. Sysmex Xtra Online. 1-2.

Rosa A, Jose R. Immature platelet fraction: A New Prognostic Marker in Acute Coronary Syndrome.J.Spain. 2013;66(2);145-154.

Torry S,Panda L, Ongkowijaya J. Gambaran Faktor Resiko Penderita Sindrom Koroner Akut, Bagian Ilmu Penyakit Dalam FK Unstrat,

Kurniawan L.B, Bahrun U, Rauf D, Arif M,Analisis Kaitan Jumlah Trombosit dengan Mortalitas Pasien Infark Miokard Akut selama Parawatan. Cermin Dunia Kedokteran,2014;41(09); 647-649.

Loo B, Marin JF. A Role for Changes in Platelet Production in the Cause of Acute Coronary Syndromes. Arteriosclerosis Thrombosis Vascular Biology. 1998;672-676.

Sukmawaty. MPV: Penanda Prognostik pada pasien SKA. Available Platelet Volume. Accesed on Agustus 14th 2017.

Groove, et al. Immatute Platelet Fraction in Patients after Acute Coronary Syndrome Journal of Clinical & Laboratory Investigation, 2011;71:613–619.

Myrtha R, Patofisiologi Sindrom Koroner Akut. Cermin Dunia Kedokteran. Vol.39. 2012; 261.



  • There are currently no refbacks.